Page 7 - Market Outlook

These 33 stocks on Nifty500 index have hit record highs; more gains likely

Stocks hitting a 52-week high or new all-time high early in the year tend to have more legs for an upside for the rest of the year.

DLF, Oberoi Realty: Rally in real estate stocks has more legs, charts show

The Nifty Realty index can rally towards 525-level.

Macro data, quarterly earnings to guide equity market this week: Analysts

IT companies Infosys, TCS, Wipro, HCL Tech and Mindtree would announce their numbers.

Bajaj Hind, Dwarikesh: Stay invested in sugar stocks for up to 33% gain

Major sugar stocks are ready to claim new bullish territory

India Cement, ACC: Breakout in cement stocks signal up to 11% rise

Ambuja Cements and India Cements charts indicate breakout of 'Inverse Head and Shoulder' pattern, thus a bullish trend ahead.

Bulls in-charge: Over 50% stocks from Nifty500 trade above major support

Stocks like Asian Paints, Astral, Balrampur Chini, Birlasoft, Carborundum Universal, eClerx, Infosys, Max Healthcare, Tube Investments and Torrent Pharma and others are trading at life-time highs

Infy, TCS, Coforge: IT stocks could be the best bets this earnings season

The major IT stocks like Infosys, LTI, Coforge continue to absorb selling pressure at the counters

Tata Motors, Eicher, Maruti: Will auto shares breakout for bigger gains?

Automobile shares may breakout after crossing significant resistances

IT services, telecom, financials: Sectors analysts are betting on for 2022

With the withdrawal of easy and cheap money globally, fundamentals would come to fore, analysts suggest. Therefore, one needs to stay invested in the right quality of stocks, analysts suggest

Buy these mid, smallcap stocks for at least 20% returns in 2022

Laurus Labs Ltd, Endurance Technologies Ltd may surge over 30 per cent whereas small cap stocks like Avanti Feeds Ltd, BASF India and Rain Industries could jump up to 40 per cent from current levels

Sensex can hit 70,000 in 2022; Nifty set to conquer 21,000, charts suggest

The Indian benchmarks are set to climb higher in 2022. Though there can be intermittent corrections, the broad trend remains up. Here is how key indices are stacked up the on technical charts

Markets will look past Omicron scare and move higher: Analysts

Back home, India has logged 653 cases of the Omicron variant of coronavirus across 21 states and Union Territories so far. Of this, 186 have recovered or migrated, official data suggested on Tuesday

IndiGo, PVR: These recovery-plays can surge up to 11% despite Omicron woes

These stocks have corrected between 10-20 per cent over the last one month relative to benchmarks' 3 per cent fall. Here's a possible way forward for these stocks

Axis, RBL, IndusInd: Pvt banks may provide shorting opportunites on rise

A Death Cross, Descending triangle and a breach of significant levels reflect downside up to 16% for these banking shares

FIIs expected to return to the Indian equity market in 2022: Abhijit Bhave

The recent FII outflows can also be viewed as a year-end phenomenon and a possible knee-jerk reaction to recent events, Bhave said

RIL, HCL Tech: These 7 oversold stocks are set to lead market recovery

The underneath strength, preferably read as price action, has been able to hold ground around the major neckline supports for these stocks

Omicron scare, FPI sell-off: Here's what spooked the markets on Monday

Analysts expect the downtrend to be arrested soon and steep correction will lead to value buying at lower levels

EM equities to underperform in 2022 on central bank policy action: Analysts

While most analysts see monetary policy normalisation across the world in 2022, rate trajectories are likely to diverge across geographies, they said

Nifty longs can be held with a stop at 17,200, recommends Vinay Rajani

The technical analyst from HDFC Securities expects CDSL and Polycab to perform well

Market outlook 2022: Brokerages remain upbeat; see Sensex at new high

Inflation, winding down of stimulus from major central banks such as the US Fed and the ECB, developments in China and the impact of the new Covid variants, if any, are some of the key risks